Complete Filing Data
Viking Therapeutics, Inc. reported Stockholders Equity Including Portion Attributable To Noncontrolling Interest of $639.06 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Viking Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$359.6M | -$110.0M | -$85.9M | -$68.9M | -$55.0M | -$39.5M | -$25.8M | -$22.1M | -$20.6M | -$14.7M | -$23.4M | -$21.9M |
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Research And Development Expense | $345.0M | $101.6M | $63.8M | $54.2M | $45.0M | $31.9M | $23.6M | $19.0M | $13.7M | $9.0M | $7.0M | $22.2M |
| Other Nonoperating Income Expense | $33.7M | $41.0M | $14.9M | $1.5M | $692.0K | $3.2M | $6.9M | $4.1M | -$1.5M | -$884.5K | -$11.4M | $1.6M |
| Operating Income Loss | -$393.3M | -$150.9M | -$100.8M | -$70.4M | -$55.7M | -$42.7M | -$32.7M | -$26.2M | -$19.1M | -$13.8M | -$12.0M | -$23.5M |
| Operating Expenses | $393.3M | $150.9M | $100.8M | $70.4M | $55.7M | $42.7M | $32.7M | $26.2M | $19.1M | $13.8M | $12.0M | $23.5M |
| General And Administrative Expense | $48.4M | $49.3M | $37.0M | $16.1M | $10.7M | $10.7M | $9.1M | $7.1M | $5.3M | $4.8M | $5.0M | $1.2M |
| Interest Income Expense Nonoperating Net | $33.7M | $40.9M | $15.0M | $1.6M | $703.0K | $3.2M | $7.1M | $3.2M | $1.0K | -$21.9K | -$88.7K | -$70.7K |
| Comprehensive Income Net Of Tax | -$358.5M | -$110.4M | -$85.2M | -$69.4M | -$55.5M | -$39.6M | -$25.3M | -$22.5M | -$20.6M | -$14.7M | -$23.4M | -$21.9M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $1.1M | -$173.0K | $742.0K | -$295.0K | -$495.0K | -$66.0K | $435.0K | -$403.0K | -$13.0K | $478.00 | -$7.4K | |
| Operating Leases Interest Expense | $10.0K | $38.0K | $43.0K | $41.0K | $11.0K | $32.0K | $48.0K | |||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $47.0K | -$226.0K | -$29.0K | -$258.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$90.8M | -$65.6M | -$45.6M | -$24.9M | -$22.3M | -$27.4M | -$22.5M | -$19.2M | -$19.5M | -$15.8M | -$17.4M | -$16.1M | -$13.2M | -$15.4M | -$14.0M | -$9.3M | -$9.6M | -$9.7M | -$5.7M | -$7.7M | -$4.9M | -$6.6M | -$6.7M | -$3.6M | -$6.1M | -$5.2M | -$5.2M | -$3.8M | -$3.7M | -$3.6M | -$4.7M | -$7.9M | -$5.7M | -$261.8K | -$22.8M | -$228.9K |
| Revenue * | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Research And Development Expense | $90.0M | $60.2M | $41.4M | $22.8M | $23.8M | $24.1M | $18.4M | $13.9M | $11.0M | $12.0M | $13.5M | $12.6M | $10.8M | $12.8M | $11.5M | $7.1M | $7.8M | $8.0M | $5.3M | $7.3M | $4.5M | $5.7M | $5.2M | $3.0M | $3.5M | $3.7M | $3.5M | $2.1M | $2.4M | $1.9M | $2.5M | $1.1M | $139.0K | $788.6K | $21.2M | $50.0K |
| Other Nonoperating Income Expense | $7.8M | $9.0M | $9.8M | $11.6M | $11.8M | $6.7M | $4.7M | $4.5M | $1.0M | $423.0K | $199.0K | $142.0K | $160.0K | $160.0K | $218.0K | $555.0K | $1.0M | $1.3M | $1.7M | $1.9M | $1.9M | $794.0K | $253.0K | $1.3M | -$1.4M | -$189.0K | -$253.0K | -$543.1K | -$114.7K | -$319.6K | -$448.3K | -$5.2M | -$5.3M | $887.2K | -$1.0M | -$19.2K |
| Operating Income Loss | -$98.6M | -$74.6M | -$55.5M | -$36.6M | -$34.1M | -$34.1M | -$27.3M | -$23.7M | -$20.5M | -$16.2M | -$17.6M | -$16.2M | -$13.4M | -$15.5M | -$14.2M | -$9.8M | -$10.6M | -$10.9M | -$7.4M | -$9.6M | -$6.8M | -$7.4M | -$6.9M | -$4.8M | -$4.7M | -$5.0M | -$5.0M | -$3.3M | -$3.6M | -$3.3M | -$4.3M | -$2.6M | -$461.0K | -$1.1M | -$21.8M | -$209.7K |
| Operating Expenses | $98.6M | $74.6M | $55.5M | $36.6M | $34.1M | $34.1M | $27.3M | $23.7M | $20.5M | $16.2M | $17.6M | $16.2M | $13.4M | $15.5M | $14.2M | $9.8M | $10.6M | $10.9M | $7.4M | $9.6M | $6.8M | $7.4M | $6.9M | $4.8M | $4.7M | $5.0M | $5.0M | $3.3M | $3.6M | $3.3M | $4.3M | $2.6M | $461.0K | $1.1M | $21.8M | $209.7K |
| General And Administrative Expense | $8.6M | $14.4M | $14.1M | $13.8M | $10.3M | $10.0M | $8.9M | $9.8M | $9.5M | $4.2M | $4.1M | $3.7M | $2.6M | $2.7M | $2.7M | $2.7M | $2.8M | $3.0M | $2.2M | $2.2M | $2.3M | $1.7M | $1.7M | $1.8M | $1.2M | $1.3M | $1.4M | $1.2M | $1.2M | $1.4M | $1.8M | $1.5M | $322.1K | $360.4K | $514.0K | $159.7K |
| Interest Income Expense Nonoperating Net | $7.8M | $9.0M | $9.9M | $11.5M | $11.8M | $6.7M | $4.7M | $4.5M | $1.0M | $450.0K | $253.0K | $154.0K | $125.0K | $181.0K | $239.0K | $576.0K | $1.0M | $1.3M | $1.7M | $1.9M | $1.9M | $824.0K | $392.0K | $181.0K | $2.0K | -$1.0K | -$2.0K | -$1.6K | -$1.8K | -$15.5K | -$10.3K | -$29.8K | -$35.3K | -$25.0K | -$9.5K | |
| Comprehensive Income Net Of Tax | -$90.2M | -$65.5M | -$45.1M | -$21.0M | -$22.9M | -$28.6M | -$22.4M | -$19.6M | -$19.0M | -$15.9M | -$17.7M | -$17.0M | -$13.2M | -$15.5M | -$14.1M | -$9.7M | -$8.4M | -$10.5M | -$5.8M | -$7.4M | -$4.6M | -$6.6M | -$6.7M | -$3.6M | -$6.1M | -$5.2M | -$5.2M | -$3.8M | -$3.7M | -$3.6M | -$4.7M | -$7.9M | -$5.7M | -$261.8K | -$22.8M | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $540.0K | $26.0K | $563.0K | $3.9M | -$699.0K | -$1.1M | $221.0K | -$417.0K | $501.0K | $111.0K | -$31.0K | -$893.0K | $19.0K | -$85.0K | -$50.0K | -$379.0K | $1.1M | -$824.0K | -$82.0K | $288.0K | $374.0K | $30.0K | -$38.0K | -$89.0K | $2.0K | $2.0K | -$1.0K | $649.00 | -$6.6K | $7.2K | $7.6K | -$12.5K | ||||
| Operating Leases Interest Expense | $10.0K | $9.0K | $12.0K | $4.0K | $5.0K | $10.0K | $13.0K | |||||||||||||||||||||||||||||
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $0.00 | $24.0K | $9.0K | $2.0K | $26.0K | -$85.0K | -$86.0K | -$5.0K | -$17.0K | -$223.0K | -$207.0K | $31.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $639.1M | $880.3M | $348.4M | $145.3M | $201.9M | $244.3M | $277.1M | $297.8M | $13.5M | $8.0M | $8.7M | -$22.1M | -$250.6K |
| Cash And Cash Equivalents At Carrying Value | $165.8M | $26.7M | $55.5M | $36.6M | $26.4M | $29.1M | $8.4M | $24.8M | $3.1M | $768.6K | $755.9K | $179.6K | |
| Amortization Of Financing Costs Equity Transactions | $56.0K | $94.0K | $88.0K | $59.0K | $18.0K | $106.0K | $146.0K | $120.0K | $571.0K | $138.7K | |||
| Additional Paid In Capital Common Stock | $1.49B | $1.37B | $733.5M | $445.3M | $425.6M | $412.6M | $405.8M | $401.1M | $94.3M | $68.3M | $54.3M | $12.9K | |
| Retained Earnings Accumulated Deficit | -$847.5M | -$487.9M | -$377.9M | -$292.0M | -$223.2M | -$168.2M | -$128.7M | -$102.9M | -$80.9M | -$60.3M | -$45.5M | -$22.1M | |
| Prepaid Expense And Other Assets Current | $1.8M | $1.1M | $2.5M | $3.4M | $619.0K | $442.0K | $405.0K | $278.0K | $389.0K | $282.7K | $1.1M | $17.8K | |
| Other Accrued Liabilities Current | $23.3M | $17.1M | $11.3M | $13.1M | $7.3M | $7.8M | $4.0M | $3.6M | $2.3M | $1.2M | $1.4M | $380.3K | |
| Liabilities Current | $76.7M | $27.4M | $19.1M | $21.9M | $8.8M | $12.1M | $6.8M | $4.6M | $8.7M | $6.5M | $2.0M | $22.5M | |
| Liabilities And Stockholders Equity | $715.7M | $908.3M | $368.5M | $168.5M | $210.7M | $256.5M | $284.3M | $302.3M | $22.1M | $14.5M | $15.4M | $3.0M | |
| Liabilities | $76.7M | $28.0M | $20.1M | $23.2M | $8.8M | $12.2M | $7.1M | $4.6M | $8.7M | $6.5M | $6.7M | $25.2M | |
| Assets Current | $715.6M | $907.2M | $367.2M | $167.0M | $210.5M | $256.1M | $283.5M | $302.1M | $21.9M | $14.0M | $15.2M | $773.7K | |
| Assets | $715.7M | $908.3M | $368.5M | $168.5M | $210.7M | $256.5M | $284.3M | $302.3M | $22.1M | $14.5M | $15.4M | $3.0M | |
| Accounts Payable Current | $53.3M | $9.8M | $7.5M | $8.5M | $1.4M | $4.0M | $2.4M | $959.0K | $1.5M | $1.2M | $592.4K | $1.8M | |
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $358.00 | $208.00 | $97.00 | $60.00 | |
| Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $378.0K | -$788.0K | -$389.0K | -$1.1M | -$549.0K | -$54.0K | $12.0K | -$423.0K | -$20.0K | -$6.9K | -$7.4K | ||
| Deposits Assets Noncurrent | $46.0K | $46.0K | $33.0K | $33.0K | $33.0K | $29.0K | $29.0K | $29.0K | $39.3K | $80.0K | $775.00 | ||
| Liabilities Noncurrent | $0.00 | $630.0K | $936.0K | $1.3M | $29.0K | $360.0K | $12.0K | $16.3K | $4.7M | $2.7M | |||
| Unpaid Deferred Initial Public Offering And Other Financing Costs | $50.0K | $50.0K | $50.0K | $31.0K | $50.0K | $50.0K | $50.0K | $140.0K | $108.8K | ||||
| Change In Fair Value Of Debt Conversion Features | $0.00 | $1.4M | $345.0K | $1.1M | -$1.0M | $390.8K | |||||||
| Amortization Of Debt Discount Premium | $0.00 | $404.0K | $1.3M | $1.8M | $893.5K | $558.0K | |||||||
| Debt Securities Available For Sale Realized Gain Loss | $0.00 | -$42.0K | $0.00 | $40.0K | $4.0K | -$12.0K | $0.00 | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $165.8M | $26.7M | $55.5M | $36.6M | $26.4M | $29.1M | |||||||
| Operating Lease Right Of Use Asset | $85.0K | $1.0M | $1.1M | $1.4M | $25.0K | $321.0K | $598.0K | ||||||
| Operating Lease Liability Current | $137.0K | $489.0K | $324.0K | $304.0K | $29.0K | $330.0K | $302.0K | ||||||
| Change In Accrued Interest Relating To Marketable Securities Held As Investments | -$5.1M | -$1.2M | -$321.0K | -$614.0K | -$1.2M | -$2.6M | -$2.0M | ||||||
| Operating Lease Liability Noncurrent | $0.00 | $630.0K | $936.0K | $1.3M | $29.0K | $360.0K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $36.6M | $26.4M | $29.1M | $8.4M | $24.8M | $9.0M | |||||||
| Cash And Cash Equivalents Period Increase Decrease | $15.8M | $5.9M | $2.3M | $12.7K | $576.2K | ||||||||
| Deferred Public Offering And Other Financing Costs Noncurrent | $76.0K | $48.0K | $128.0K | $150.0K | $270.0K | $521.5K | $157.5K | ||||||
| Deferred Financing Costs Non Current | $0.00 | $56.0K | $106.0K | $38.0K | $76.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $713.0M | $795.5M | $846.9M | $911.4M | $921.0M | $933.9M | $368.2M | $386.1M | $134.1M | $151.3M | $165.2M | $182.3M | $213.1M | $225.0M | $237.2M | $253.8M | $261.9M | $268.3M | $283.5M | $288.4M | $294.6M | $302.1M | $140.4M | $72.6M | $2.2M | $6.6M | $7.5M | $10.2M | $12.8M | $5.8M | $13.3M | $17.4M | -$27.8M | |||||
| Cash And Cash Equivalents At Carrying Value | $100.4M | $33.9M | $37.9M | $50.3M | $43.9M | $195.6M | $37.2M | $69.5M | $18.4M | $29.4M | $16.2M | $12.5M | $11.3M | $8.8M | $16.8M | $3.9M | $18.8M | $15.3M | $31.0M | $19.1M | $14.3M | $169.5M | $34.6M | $36.4M | $9.0M | $2.6M | $3.4M | $4.4M | $3.1M | $5.2M | $4.0M | $2.1M | $9.5M | $327.0K | $794.4K | $891.5K | $78.8K | |
| Amortization Of Financing Costs Equity Transactions | $8.0K | $24.0K | $24.0K | $24.0K | $18.0K | $28.0K | $2.0K | $32.0K | $28.0K | $27.0K | $12.0K | $12.0K | -$35.0K | $21.0K | $21.0K | $20.0K | $20.0K | $45.0K | $40.0K | $30.0K | $30.0K | $30.0K | $30.0K | $30.0K | $17.0K | $422.0K | $98.0K | $45.9K | ||||||||||
| Additional Paid In Capital Common Stock | $1.40B | $1.39B | $1.38B | $1.36B | $1.35B | $1.34B | $729.3M | $724.8M | $453.1M | $432.3M | $430.4M | $428.1M | $424.1M | $422.7M | $419.5M | $411.1M | $409.6M | $407.5M | $404.6M | $403.6M | $402.5M | $399.8M | $231.6M | $157.1M | $79.0M | $77.3M | $73.1M | $66.9M | $65.6M | $54.9M | $53.7M | $53.1M | $13.8K | |||||
| Retained Earnings Accumulated Deficit | -$689.9M | -$599.1M | -$533.5M | -$452.5M | -$427.6M | -$405.3M | -$353.3M | -$330.8M | -$311.6M | -$272.5M | -$256.7M | -$239.3M | -$210.8M | -$197.6M | -$182.2M | -$157.2M | -$148.0M | -$138.4M | -$121.2M | -$115.5M | -$107.8M | -$97.7M | -$91.1M | -$84.4M | -$76.8M | -$70.7M | -$65.5M | -$56.6M | -$52.8M | -$49.1M | -$40.5M | -$35.7M | -$27.9M | |||||
| Prepaid Expense And Other Assets Current | $2.2M | $2.8M | $865.0K | $1.7M | $138.0K | $643.0K | $670.0K | $960.0K | $3.9M | $956.0K | $1.1M | $388.0K | $915.0K | $1.2M | $625.0K | $710.0K | $914.0K | $547.0K | $572.0K | $665.0K | $251.0K | $607.0K | $593.0K | $249.0K | $340.1K | $447.9K | $177.5K | $1.0M | $1.1M | $909.9K | $1.4M | $610.2K | $33.4K | |||||
| Other Accrued Liabilities Current | $21.2M | $26.0M | $11.4M | $25.0M | $13.7M | $27.2M | $7.4M | $7.6M | $11.5M | $10.6M | $8.5M | $8.0M | $8.4M | $8.5M | $7.8M | $6.6M | $5.5M | $5.1M | $3.8M | $3.5M | $3.0M | $3.5M | $2.6M | $1.9M | $2.8M | $2.4M | $1.7M | $996.4K | $852.7K | $745.8K | $1.1M | $119.6K | $517.9K | |||||
| Liabilities Current | $26.1M | $32.0M | $19.6M | $25.7M | $25.1M | $32.8M | $13.4M | $13.5M | $15.6M | $14.1M | $14.9M | $11.3M | $11.4M | $12.9M | $12.9M | $9.7M | $9.1M | $8.5M | $6.2M | $5.6M | $4.9M | $4.7M | $4.1M | $6.3M | $9.6M | $7.7M | $3.4M | $6.1M | $5.7M | $1.9M | $5.7M | $4.9M | $27.7M | |||||
| Liabilities And Stockholders Equity | $739.4M | $827.9M | $867.0M | $937.9M | $946.8M | $967.5M | $382.7M | $400.7M | $150.9M | $166.7M | $181.5M | $195.0M | $224.5M | $237.8M | $250.1M | $263.6M | $271.2M | $277.1M | $290.1M | $294.5M | $300.1M | $306.8M | $144.5M | $79.0M | $11.8M | $14.3M | $15.2M | $16.3M | $18.5M | $12.8M | $19.0M | $22.3M | $2.8M | |||||
| Liabilities | $26.4M | $32.4M | $20.1M | $26.4M | $25.9M | $33.6M | $14.4M | $14.6M | $16.8M | $15.4M | $16.3M | $12.8M | $11.4M | $12.9M | $12.9M | $9.8M | $9.3M | $8.8M | $6.6M | $6.1M | $5.5M | $4.7M | $4.1M | $6.3M | $9.6M | $7.7M | $7.6M | $6.1M | $5.8M | $7.0M | $5.7M | $4.9M | $30.6M | |||||
| Assets Current | $738.7M | $827.0M | $866.0M | $936.6M | $945.7M | $966.3M | $381.3M | $399.4M | $149.5M | $165.1M | $179.9M | $193.3M | $224.3M | $237.7M | $249.9M | $263.1M | $270.6M | $276.4M | $289.3M | $293.6M | $299.1M | $306.6M | $144.3M | $78.7M | $11.5M | $14.3M | $14.7M | $15.6M | $18.3M | $12.2M | $18.9M | $22.3M | $360.4K | |||||
| Assets | $739.4M | $827.9M | $867.0M | $937.9M | $946.8M | $967.5M | $382.7M | $400.7M | $150.9M | $166.7M | $181.5M | $195.0M | $224.5M | $237.8M | $250.1M | $263.6M | $271.2M | $277.1M | $290.1M | $294.5M | $300.1M | $306.8M | $144.5M | $79.0M | $11.8M | $14.3M | $15.2M | $16.3M | $18.5M | $12.8M | $19.0M | $22.3M | $2.8M | |||||
| Accounts Payable Current | $4.4M | $5.5M | $7.7M | $254.0K | $11.1M | $5.2M | $5.7M | $5.6M | $3.8M | $3.1M | $6.1M | $3.1M | $2.9M | $4.2M | $4.8M | $2.8M | $3.2M | $3.1M | $2.1M | $1.9M | $1.7M | $1.2M | $1.5M | $658.0K | $1.6M | $1.3M | $1.7M | $881.3K | $1.2M | $1.2M | $401.7K | $1.0M | $1.9M | |||||
| Common Stock Value | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $285.00 | $277.00 | $239.00 | $199.00 | $193.00 | $97.00 | $98.00 | $98.00 | $60.00 | |||||
| Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $374.0K | -$166.0K | -$216.0K | $1.6M | -$2.3M | -$1.6M | -$905.0K | -$1.0M | -$618.0K | -$1.8M | -$1.6M | -$1.4M | -$170.0K | -$189.0K | -$104.0K | -$46.0K | $333.0K | -$812.0K | $157.0K | $239.0K | -$49.0K | -$117.0K | -$147.0K | -$109.0K | -$3.6K | -$6.0K | -$7.5K | -$6.1K | -$6.8K | -$195.00 | -$4.8K | -$12.5K | ||||||
| Deposits Assets Noncurrent | $46.0K | $46.0K | $46.0K | $46.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $33.0K | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $29.0K | $39.3K | $39.3K | $39.3K | $80.0K | $80.0K | $80.0K | ||||||||||||||
| Liabilities Noncurrent | $318.0K | $410.0K | $502.0K | $755.0K | $766.0K | $852.0K | $1.0M | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M | $115.0K | $198.0K | $279.0K | $438.0K | $513.0K | $588.0K | $6.1K | $4.2M | $20.5K | $24.6K | $5.1M | $19.1K | $2.9M | |||||||||||||
| Unpaid Deferred Initial Public Offering And Other Financing Costs | $50.0K | $69.0K | $52.0K | $50.0K | $50.0K | $66.0K | $136.0K | $16.0K | $409.4K | |||||||||||||||||||||||||||||
| Change In Fair Value Of Debt Conversion Features | $0.00 | $0.00 | $0.00 | $0.00 | $37.0K | $1.4M | -$1.1M | $571.0K | $278.0K | -$64.5K | $412.1K | $96.5K | -$197.5K | -$546.5K | -$82.7K | $413.7K | -$2.3K | $10.2K | ||||||||||||||||||||
| Amortization Of Debt Discount Premium | $0.00 | $0.00 | $0.00 | $0.00 | $146.0K | $258.0K | $256.0K | $337.0K | $431.0K | $431.2K | $525.0K | $400.7K | $240.5K | $240.5K | $172.0K | $196.7K | $60.6K | $6.4K | ||||||||||||||||||||
| Debt Securities Available For Sale Realized Gain Loss | $0.00 | $0.00 | $0.00 | -$42.0K | $0.00 | $0.00 | $0.00 | -$1.0K | $14.0K | $2.0K | $6.0K | $0.00 | -$2.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $100.4M | $33.9M | $37.9M | $50.3M | $43.9M | $195.6M | $37.2M | $69.5M | $18.4M | $29.4M | $16.2M | $12.5M | $11.3M | $8.8M | ||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $666.0K | $780.0K | $892.0K | $1.1M | $977.0K | $1.1M | $1.2M | $1.3M | $1.3M | $1.5M | $1.6M | $1.6M | $101.0K | $176.0K | $249.0K | $392.0K | $462.0K | $530.0K | $664.0K | $730.0K | $794.0K | |||||||||||||||||
| Operating Lease Liability Current | $437.0K | $468.0K | $498.0K | $480.0K | $334.0K | $329.0K | $319.0K | $314.0K | $309.0K | $299.0K | $238.0K | $150.0K | $115.0K | $198.0K | $279.0K | $323.0K | $316.0K | $309.0K | $295.0K | $288.0K | $281.0K | |||||||||||||||||
| Change In Accrued Interest Relating To Marketable Securities Held As Investments | -$2.5M | -$655.0K | -$243.0K | -$105.0K | $166.0K | -$748.0K | ||||||||||||||||||||||||||||||||
| Operating Lease Liability Noncurrent | $318.0K | $410.0K | $502.0K | $755.0K | $766.0K | $852.0K | $1.0M | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M | $115.0K | $198.0K | $279.0K | $438.0K | $513.0K | $588.0K | ||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $12.5M | $11.3M | $8.8M | $16.8M | $3.9M | $18.8M | $15.3M | $31.0M | $19.1M | $14.3M | $169.5M | |||||||||||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$10.4M | $27.4M | $1.3M | $3.2M | -$428.9K | -$100.8K | ||||||||||||||||||||||||||||||||
| Deferred Public Offering And Other Financing Costs Noncurrent | $68.0K | $89.0K | $99.0K | $173.0K | $90.0K | $120.0K | $180.0K | $210.0K | $240.0K | $275.0K | $17.6K | $439.3K | $614.4K | |||||||||||||||||||||||||
| Deferred Financing Costs Non Current | $0.00 | $8.0K | $32.0K | $80.0K | $105.0K | $98.0K | $130.0K | $16.0K | $48.0K | $15.0K | $52.0K | $64.0K | $88.0K | $7.0K | $27.0K | $48.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $76.4M | $612.5M | $271.4M | $4.2M | $6.9M | $950.0K | $887.0K | $300.3M | $22.4M | $10.3M | $22.2M | $2.2M |
| Investing Cash Flow * | $341.4M | -$553.4M | -$179.1M | $54.8M | $38.0M | $41.6M | $7.5M | -$265.7M | -$1.7M | $3.0M | -$13.5M | |
| Operating Cash Flow * | -$278.7M | -$87.8M | -$73.4M | -$48.4M | -$47.6M | -$21.8M | -$24.8M | -$18.8M | -$14.8M | -$11.1M | -$8.7M | -$1.6M |
| Share Based Compensation | $40.8M | $29.7M | $16.8M | $8.7M | $6.1M | $5.8M | $3.7M | $2.6M | $1.5M | $1.8M | $2.6M | $6.3K |
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $40.8M | $29.7M | $16.8M | $8.7M | $6.1M | $5.8M | $3.6M | $2.5M | $1.4M | $1.8M | $2.2M | $3.8K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $5.2M | -$446.0K | -$6.4M | $3.1M | $711.0K | -$137.0K | $7.4M | $137.0K | -$497.0K | -$273.3K | $1.1M | $17.8K |
| Increase Decrease In Accounts Payable | $43.4M | $2.3M | -$1.0M | $7.1M | -$2.5M | $1.6M | $1.5M | -$508.0K | $264.0K | $677.2K | $219.2K | $191.0K |
| Payments To Acquire Investments | $418.0M | $1.11B | $478.3M | $121.4M | $168.0M | $280.6M | $362.4M | $348.2M | $22.5M | $16.9M | $16.0M | |
| Proceeds From Sale Maturity And Collections Of Investments | $759.4M | $560.0M | $299.2M | $176.2M | $206.0M | $322.2M | $369.9M | $82.5M | $20.8M | $20.0M | $2.6M | |
| Stock Issued During Period Value Share Based Compensation Gross | $2.5M | $10.8M | $6.8M | $215.0K | $570.0K | $418.0K | $328.0K | $560.0K | $73.0K | |||
| Increase Decrease In Accrued Liabilities | $6.2M | $5.8M | -$1.8M | $5.8M | -$506.0K | $3.8M | $423.0K | $1.5M | $1.0M | -$141.3K | $1.6M | $81.0K |
| Payments Related To Tax Withholding For Share Based Compensation | $0.00 | $42.1M | $7.1M | $1.5M | $707.0K | $296.0K | $151.0K | $127.0K | $22.0K | $31.1K | $418.4K | |
| Payments Of Stock Issuance Costs | $22.0K | $46.0K | $26.0K | $73.0K | $765.0K | $500.0K | $1.1M | $2.8M | $332.3K | |||
| Increase Decrease In Operating Lease Liability | -$505.0K | -$402.0K | -$347.0K | -$189.0K | -$342.0K | -$333.0K | -$269.0K | |||||
| Proceeds From Warrant And Option Exercises And Stock Issuance Under Employee Stock Purchase Plan | $2.5M | $10.8M | $6.8M | $848.0K | $7.6M | |||||||
| Proceeds From Issuance Of Common Stock | $296.6M | $22.4M | $11.5M | $25.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $349.0K | $606.0M | $4.2M | -$5.0M | $5.2M | $33.0K | $325.0K | $62.3M | $2.5M | -$57.3K | -$17.9K | -$2.00 | ||||||||||||||||||||||
| Investing Cash Flow * | $63.2M | -$459.8M | $2.2M | $1.6M | -$6.6M | $11.2M | -$7.6M | -$29.6M | $2.0M | $6.0M | ||||||||||||||||||||||||
| Operating Cash Flow * | -$52.3M | -$6.1M | -$24.6M | -$10.5M | -$10.9M | -$4.3M | -$3.2M | -$5.3M | -$3.3M | -$2.7M | -$410.9K | -$100.8K | ||||||||||||||||||||||
| Share Based Compensation | $7.3M | $13.5M | $11.3M | $9.0M | $7.1M | $8.0M | $4.5M | $4.6M | $3.6M | $1.9M | $2.2M | $2.4M | $1.6M | $1.5M | $1.6M | $1.5M | $1.6M | $1.7M | $811.0K | $922.0K | $1.0M | $750.0K | $630.0K | $610.0K | $344.0K | $341.0K | $402.0K | $321.0K | $490.2K | $624.6K | $601.6K | $1.5M | $903.00 | $904.00 |
| Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition | $7.3M | $13.5M | $11.3M | $9.0M | $7.1M | $8.0M | $4.5M | $4.6M | $3.6M | $1.9M | $2.2M | $2.4M | $1.6M | $1.5M | $1.6M | $1.5M | $1.6M | $1.7M | $810.0K | $884.0K | $949.0K | $747.0K | $531.0K | $610.0K | $344.0K | |||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $9.6M | -$1.7M | $2.3M | -$23.0K | $266.0K | -$569.0K | -$75.0K | $316.0K | -$221.0K | -$187.7K | $15.6K | $7.5K | ||||||||||||||||||||||
| Increase Decrease In Accounts Payable | -$2.1M | -$2.3M | -$4.7M | $1.7M | $860.0K | $650.0K | $716.0K | -$832.0K | $523.0K | $449.7K | $37.3K | $115.6K | ||||||||||||||||||||||
| Payments To Acquire Investments | $232.6M | $596.6M | $57.4M | $30.7M | $48.7M | $56.4M | $99.2M | $32.3M | $6.1M | $149.4K | ||||||||||||||||||||||||
| Proceeds From Sale Maturity And Collections Of Investments | $295.9M | $136.8M | $59.6M | $32.3M | $42.0M | $67.6M | $91.6M | $2.7M | $8.1M | $6.1M | ||||||||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation Gross | $480.0K | $2.5M | $2.9M | $4.4M | $2.6M | $4.0M | $84.0K | $6.0K | $343.0K | $156.0K | $105.0K | $227.0K | $12.0K | $90.0K | $107.0K | $65.0K | $157.0K | $242.0K | $73.0K | |||||||||||||||
| Increase Decrease In Accrued Liabilities | -$5.7M | $15.9M | -$1.6M | $694.0K | $1.8M | -$168.0K | -$428.0K | $472.0K | -$752.7K | $62.7K | $2.6K | |||||||||||||||||||||||
| Payments Related To Tax Withholding For Share Based Compensation | $42.1M | $1.7M | $499.0K | $473.0K | $127.0K | $84.0K | ||||||||||||||||||||||||||||
| Payments Of Stock Issuance Costs | $37.0K | $146.0K | $16.0K | $57.3K | $17.9K | |||||||||||||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$129.0K | -$88.0K | -$85.0K | -$76.0K | -$85.0K | -$83.0K | -$27.0K | |||||||||||||||||||||||||||
| Proceeds From Warrant And Option Exercises And Stock Issuance Under Employee Stock Purchase Plan | $4.0M | $614.0K | $5.7M | $160.0K | $409.0K | $3.6M | ||||||||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $58.8M | $2.5M | $7.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.19 | -$1.01 | -$0.91 | -$0.90 | -$0.71 | -$0.54 | -$0.36 | -$0.38 | -$0.79 | -$0.90 | -$3.68 | -$5.23 |
| Common Stock Shares Issued | 114.8M | 111.6M | 100.1M | 78.3M | 78.2M | 73.2M | 72.4M | 71.7M | 35.8M | 20.8M | 9.7M | 6.0M |
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 25.0M |
| Common Stock Shares Outstanding | 114.8M | 111.6M | 100.1M | 78.3M | 78.2M | 73.2M | 72.4M | 71.7M | 35.8M | 20.8M | 9.7M | 6.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 0.00 |
| Weighted Average Number Of Share Outstanding Basic And Diluted | 77.2M | 72.6M | 72.0M | 57.6M | 26.0M | 16.3M | 6.4M | 4.2M | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 112.7M | 109.0M | 94.3M | 76.8M | 77.2M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 112.7M | 109.0M | 94.3M | 76.8M | 77.2M | |||||||
| Earnings Per Share Basic | $-3.19 | $-1.01 | $-0.91 | $-0.90 | $-0.71 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.81 | -$0.58 | -$0.41 | -$0.22 | -$0.20 | -$0.26 | -$0.23 | -$0.19 | -$0.25 | -$0.21 | -$0.23 | -$0.21 | -$0.17 | -$0.20 | -$0.19 | -$0.13 | -$0.13 | -$0.13 | -$0.08 | -$0.11 | -$0.07 | -$0.11 | -$0.13 | -$0.10 | -$0.22 | -$0.21 | -$0.23 | -$0.20 | -$0.22 | -$0.40 | -$0.53 | -$1.07 | -$1.40 | -$0.06 | -$5.40 | -$0.08 |
| Common Stock Shares Issued | 112.4M | 112.3M | 112.3M | 111.4M | 110.8M | 110.2M | 100.0M | 100.0M | 79.3M | 76.7M | 76.7M | 77.4M | 78.2M | 78.2M | 77.2M | 72.9M | 72.8M | 72.6M | 72.3M | 72.2M | 72.0M | 71.3M | 60.7M | 50.9M | 28.5M | 27.7M | 23.9M | 19.9M | 19.3M | 9.7M | 9.8M | 9.8M | 6.0M | |||
| Common Stock Shares Authorized | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 25.0M | |||
| Common Stock Shares Outstanding | 112.4M | 112.3M | 112.3M | 111.4M | 110.8M | 110.2M | 100.0M | 100.0M | 79.3M | 76.7M | 76.7M | 77.4M | 78.2M | 78.2M | 77.2M | 72.9M | 72.8M | 72.6M | 72.3M | 72.2M | 72.0M | 71.3M | 60.7M | 50.9M | 28.5M | 27.7M | 23.9M | 19.9M | 19.3M | 9.7M | 9.8M | 9.8M | 6.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 77.4M | 78.0M | 77.9M | 74.8M | 72.6M | 72.5M | 72.4M | 72.0M | 71.9M | 71.8M | 61.2M | 52.8M | 27.5M | 24.1M | 22.4M | 19.0M | 17.1M | 9.0M | 8.9M | 7.3M | 4.1M | 4.5M | 4.2M | 2.8M | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Weighted Average Number Of Shares Outstanding Basic | 112.3M | 112.1M | 112.1M | 110.9M | 110.4M | 103.5M | 99.8M | 99.0M | 78.4M | 76.5M | 76.8M | 77.4M | 78.0M | 77.9M | 71.8M | 44.6M | 22.4M | |||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 112.3M | 112.1M | 112.1M | 110.9M | 110.4M | 103.5M | 99.8M | 99.0M | 78.4M | 76.5M | 76.8M | 77.4M | 78.0M | 77.9M | 71.8M | 45.3M | 22.4M | |||||||||||||||||||
| Earnings Per Share Basic | $-0.81 | $-0.58 | $-0.41 | $-0.22 | $-0.20 | $-0.26 | $-0.23 | $-0.19 | $-0.25 | $-0.21 | $-0.23 | $-0.21 | $-0.17 | $-0.20 | $-0.07 | $-0.08 | $-0.23 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid Clinical Trial And Preclinical Study Costs | $8.1M | $3.5M | $2.6M | $8.1M | $7.8M | $7.3M | $7.5M | $335.0K | $887.0K | ||
| Stock Issued During Period Value Warrant Exercises | $633.0K | $7.1M | $846.0K | $793.0K | $7.7M | $679.0K | |||||
| Available For Sale Securities Current | $267.3M | $276.7M | $11.6M | $10.1M | $13.3M | ||||||
| Shares Withheld Related To Employee Tax Withholding Value | -42.1M | -7.1M | -1.5M | -707.0K | -296.0K | ||||||
| Investment Income Amortization Of Premium | $1.2M | $3.9M | $3.8M | $477.0K | $73.0K | $95.0K | $153.7K | $131.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prepaid Clinical Trial And Preclinical Study Costs | $21.9M | $16.5M | $13.3M | $4.5M | $3.3M | $2.7M | $4.4M | $5.5M | $9.9M | $9.2M | $9.9M | $8.0M | $7.2M | $8.3M | $7.6M | $7.1M | $6.7M | $6.7M | $612.0K | $343.0K | $168.0K | $1.8M | $1.5M | $1.0M | |||||||||
| Stock Issued During Period Value Warrant Exercises | $614.0K | $1.4M | $5.7M | $101.0K | $216.0K | $138.0K | $51.0K | $175.0K | $360.0K | $2.3M | $1.4M | $3.4M | |||||||||||||||||||||
| Available For Sale Securities Current | $204.9M | $219.4M | $224.9M | $219.3M | $251.4M | $244.2M | $253.9M | $257.1M | $273.5M | $284.4M | $134.7M | $107.6M | $41.1M | $7.3M | $8.7M | $8.0M | $11.6M | $12.0M | $7.3M | $15.3M | $12.2M | ||||||||||||
| Shares Withheld Related To Employee Tax Withholding Value | -42.1M | -5.4M | -1.7M | -499.0K | -234.0K | 473.0K | -168.0K | -127.0K | |||||||||||||||||||||||||
| Investment Income Amortization Of Premium | $62.0K | $31.0K | $48.5K |
Most recent annual filing with the SEC: February 11, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.